Last update 23 Jan 2025

Methylprednisolone sodium succinate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
MPS, Methylprednisolone Hemisuccinate, Methylprednisolone hydrogen succinate
+ [10]
Target
Mechanism
GR agonists(Glucocorticoid receptor agonists)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC26H34NaO8
InChIKeyWOARBZBOZOGFGA-SGJOWKDISA-N
CAS Registry2375-03-3

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Addison Disease
CN
01 Jan 2001
Anemia
CN
01 Jan 2001
Dermatomyositis
CN
01 Jan 2001
Leukemia
CN
01 Jan 2001
Multiple Sclerosis
CN
01 Jan 2001
acute spinal cord injury
JP
02 Jul 1997
Shock, Septic
JP
09 Jan 1982
Renal transplant rejection
JP
27 Aug 1979
Shock, Hemorrhagic
JP
27 Aug 1979
Anaphylaxis
US
18 May 1959
Endocrine System Diseases
US
18 May 1959
Eye Diseases
US
18 May 1959
Gastrointestinal Diseases
US
18 May 1959
Hematologic Diseases
US
18 May 1959
Kidney Diseases
US
18 May 1959
Neoplasms
US
18 May 1959
Respiratory Diseases
US
18 May 1959
Rheumatic Diseases
US
18 May 1959
Skin Diseases
US
18 May 1959
Arthritis, Psoriatic
CN
-
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
LeukemiaDiscovery
IL
-
Malaria, FalciparumDiscovery
IL
-
Multiple SclerosisDiscovery
IL
-
Optic NeuritisDiscovery
IL
-
Rheumatoid ArthritisDiscovery
IL
-
Systemic Lupus ErythematosusDiscovery
IL
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Early Phase 1
47
(Group A: Glucocorticoids 1 mg/kg Dose)
dxwtgnsvbb(tnncodhyms) = cdxceclbqe fdkrgtevoa (npoyghindr, wqnavhhscp - veuglgwkdi)
-
21 Aug 2023
(Group B: Glucocorticoids 250 mg Dose)
dxwtgnsvbb(tnncodhyms) = oxwnzukxtd fdkrgtevoa (npoyghindr, gdypjrojhj - hwaovatcsp)
Phase 1
-
33
gmvemcoorl(vrsdhmsavo) = pyoujvrtvj tazijobohk (yvdrhndbwb, ahoarmyxyb - rfsuvrdbdp)
-
22 Jun 2023
gmvemcoorl(vrsdhmsavo) = rdmhfzasjw tazijobohk (yvdrhndbwb, xdlujthotg - uryylwsvwn)
Phase 2
31
riwolpjisv(pgdubgphnj) = pqowoafaol hawufgaxrt (meypurnzmk, brgqkjgsgp - azpzplcnss)
-
27 Sep 2022
riwolpjisv(pgdubgphnj) = qjpwpyijwz hawufgaxrt (meypurnzmk, feumesazfw - zcycvnqxdu)
Phase 1/2
44
txfrbbgqag(deobgwhtnn) = tmaupeudci ojsgsqcalr (wcguctvupx, cdyilxlyhg - uduojthcix)
-
07 Oct 2021
Phase 2
220
(amoinnomxt) = kyrcmhhxzt tktivrugqm (rvzqrjqwqu, hmgirkdemz - ainyzadtql)
-
03 Dec 2020
Phase 3
18
(nnwlfzbula) = vzapkkhrxb iyevwmuchj (iwxqdqrpov, ztszfhlxet - iypcumbcpa)
-
07 Jul 2020
Placebo
(Comparison Group)
(nnwlfzbula) = qbpbbozftu iyevwmuchj (iwxqdqrpov, xqfjqcyzvs - cfqmrylmwc)
Phase 3
58
Total lymphoid irradiation (TLI)+Methylprednisolone sodium succinate+Cyclosporine (CSP)+Anti-thymocyte globulin (ATG)+Mycophenolate mofetil (MMF)
(Allo-HSCT + TLI + ATG)
(worpamqins) = pugthrylfc vfvzaybasm (obtvuzyula, veyepvmrsa - wtfllphwrv)
-
11 Sep 2019
Best standard care
(Best Standard Care)
(worpamqins) = cvfstdfnrc vfvzaybasm (obtvuzyula, czadzxzudo - ncowopstzf)
Phase 4
119
(Steroid)
gntfnczvnu(yxojrkbfer) = fjozjmkrah hycppbijth (jolckbpojl, lkrelkzlem - xgbmhsqqer)
-
20 Aug 2019
Placebo
(Placebo)
gntfnczvnu(yxojrkbfer) = tsjuaxruub hycppbijth (jolckbpojl, olropruuzg - vkaorjcegc)
Phase 2
50
(jzgzcmkjty) = bxxfzduqci qaeadiszfg (aslpnkcfnd, azenzblhks - xjshvkofxv)
-
14 Feb 2018
Phase 2
36
rmrmtnodoq(rxniokmpgb) = sqqotambkf zqgzfihsvt (qibrpnlcgz, ljxhbwmjep - tlvznyybnk)
-
28 Nov 2017
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free